Hypertrophic Cardiomyopathy Association

News & Updates

  • Decisions in HCM: Understanding Risk

    Decisions in HCM: Understanding Risk

    by Gordon Fox: 3rd in a series Risk is a concept we have encountered many times during our HCM journeys, and we want to help you…

  • Reflections from Capitol Hill 2025

    I do not claim to be a political expert, but I do know what I am – a passionate patient advocate who has seen how systems…

  • Lisa’s Letter – May Newsletter

    Greetings to all of our Bighearted friends, We have certainly had an eventful April and there are many updates in this letter to bring you up…

  • Learn Your Medical Therapy Options for HCM This Month

    Learn Your Medical Therapy Options for HCM This Month

    Medical Management means using medicines and other non-invasive therapies to relieve symptoms. The FDA approved Camzyos in 2022 and It’s exciting that new treatments for HCM…

  • Decisions in HCM: Why Are They So Hard?

    Decisions in HCM: Why Are They So Hard?

    by Gordon Fox: 2nd in a series Making decisions can be hard, and this is especially true when health is involved. A key reason is that…

  • Camzyos® Receives Manufacturing and Marketing Approval for HOCM in Japan

    Camzyos® Receives Manufacturing and Marketing Approval for HOCM in Japan

    2025/03/27 Bristol-Myers Squibb Company Translated from JapaneseRead the original press release (Japanese) Download the pdf file (Japanese) *The information contained in this press release (including information…

  • US FDA Updates Camzyos Label for oHCM

    U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications for Obstructive HCM Label updates include simplified twice-yearly echo monitoring…

  • Press Release: Piedmont Heart Recognized as an HCM COE

    Press Release: Piedmont Heart Recognized as an HCM COE

    Piedmont’s Hypertrophic Cardiomyopathy Program Recognized as an HCMA Center of Excellence April 18, 2025 Piedmont Heart has been recognized as a Center of Excellence by the…

  • Lisa’s Letter – April Newsletter

    It is hard to believe the first quarter of 2025 is in the history books. In the space of hypertrophic cardiomyopathy and thick heart muscle disorders,…

  • Decisions in HCM, How to Identify, Analyze and Evaluate Decisions in Your HCM Life

    by Victoria-Theresa Wyatt and Gordon Fox: First in a series What is Shared Decision-Making? Shared decision-making is a term used a lot in healthcare settings and…

  • HCMA Gifted $1500 Harrah’s Grant

    HCMA Gifted $1500 Harrah’s Grant

    HCMA Gifted $1500 Harrah’s “Funner Model Citizen Share the Wealth” Grant By Award Winner Terri Loviato April 10, 2025 Harrah’s Southern California Resort in Funner, CA…

  • April’s Topic Is Genetic Testing

    April’s Topic Is Genetic Testing

    Who should have genetic testing, and when? Suppose you have been diagnosed with HCM through an EKG, echocardiogram, and a visit with a cardiologist. Most experts…